Market Research Reports, Inc. has announced the addition of “Pulmonary Arterial Hypertension - Pipeline Review, H2 2017” research report to their offering. See more at - http://mrr.cm/UHD

1. www.MarketResearchReports.com
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.

2. www.MarketResearchReports.com
Introduction to Report
 Launch Date: September 12, 2017
 Number of Pages: 266
 Geography Coverage: Global
 Available Format: PDF
Price For Single User License: USD 2,000
Price For Site User License: USD 4,000
Price For Global User License: USD 6,000
Delivery Time: Within 24 Hours (During Working
Days)

3. www.MarketResearchReports.com
About the Report
This report provides an overview of the Pulmonary
Arterial Hypertension (Cardiovascular) pipeline
landscape.
Pulmonary arterial hypertension (PAH) is a type of
high blood pressure that occurs in the right side
of the heart and in the arteries that supply blood to
the lungs. Symptoms include chest pain, fatigue,
passing out suddenly, and swelling of the legs
(edema).

4. www.MarketResearchReports.com
Report Highlights;
This report provides comprehensive information on the
therapeutics under development for Pulmonary Arterial
Hypertension (Cardiovascular), complete with analysis
by stage of development, drug target, mechanism of
action (MoA), route of administration (RoA) and
molecule type.
The Pulmonary Arterial Hypertension (Cardiovascular)
pipeline guide also reviews of key players involved in
therapeutic development for Pulmonary Arterial
Hypertension and features dormant and discontinued
projects.
The guide covers therapeutics under Development by
Companies /Universities /Institutes, the molecules
developed by Companies in Pre-Registration, Phase III,
Phase II, Phase I, Preclinical, Discovery and Unknown
stages are 2, 6, 9, 20, 39, 3 and 1 respectively.

5. www.MarketResearchReports.com
Report Highlights; Continues…
Similarly, the Universities portfolio in Preclinical and
Discovery stages comprises 3 and 2 molecules,
respectively.
Pulmonary Arterial Hypertension (Cardiovascular)
pipeline guide helps in identifying and tracking
emerging players in the market and their portfolios,
enhances decision making capabilities and helps to
create effective counter strategies to gain competitive
advantage.
The guide is built using data and information sourced
from Publisher’s proprietary databases,
company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and
featured press releases from company/university sites
and industry-specific third party sources.

6. www.MarketResearchReports.com
Scope:
The pipeline guide provides a snapshot of the global
therapeutic landscape of Pulmonary Arterial
Hypertension (Cardiovascular).
The pipeline guide reviews pipeline therapeutics for
Pulmonary Arterial Hypertension (Cardiovascular) by
companies and universities/research institutes based
on information derived from company and industry-
specific sources.
The pipeline guide covers pipeline products based on
several stages of development ranging from pre-
registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles
for the pipeline products which comprise, product
description, descriptive licensing and collaboration
details, R&D brief, MoA & other developmental
activities.

7. www.MarketResearchReports.com
Scope: Continues…
The pipeline guide reviews key companies involved in
Pulmonary Arterial Hypertension (Cardiovascular)
therapeutics and enlists all their major and minor
projects.
The pipeline guide evaluates Pulmonary Arterial
Hypertension (Cardiovascular) therapeutics based on
mechanism of action (MoA), drug target, route of
administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and
discontinued pipeline projects.
The pipeline guide reviews latest news related to
pipeline therapeutics for Pulmonary Arterial
Hypertension (Cardiovascular)

8. www.MarketResearchReports.com
Reasons to buy:
Procure strategically important competitor information,
analysis, and insights to formulate effective R&D
strategies.
Recognize emerging players with potentially strong
product portfolio and create effective counter-strategies
to gain competitive advantage.
Find and recognize significant and varied types of
therapeutics under development for Pulmonary Arterial
Hypertension (Cardiovascular).
Classify potential new clients or partners in the target
demographic.
Develop tactical initiatives by understanding the focus
areas of leading companies.
Plan mergers and acquisitions meritoriously by
identifying key players and it’s most promising pipeline
therapeutics.

9. www.MarketResearchReports.com
Reasons to buy: Continues…
Formulate corrective measures for pipeline projects by
understanding Pulmonary Arterial Hypertension
(Cardiovascular) pipeline depth and focus of Indication
therapeutics.
Develop and design in-licensing and out-licensing
strategies by identifying prospective partners with the
most attractive projects to enhance and expand
business potential and scope.
Adjust the therapeutic portfolio by recognizing
discontinued projects and understand from the know-
how what drove them from pipeline.

10. www.MarketResearchReports.com
Report Coverage:
1. Introduction
2. Pulmonary Arterial Hypertension - Overview
3. Pulmonary Arterial Hypertension -
Therapeutics Development
4. Pulmonary Arterial Hypertension -
Therapeutics Assessment
5. Pulmonary Arterial Hypertension - Companies
Involved in Therapeutics Development
6. Pulmonary Arterial Hypertension - Drug
Profiles
7. Pulmonary Arterial Hypertension - Dormant
Projects
8. Appendix
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

11. www.MarketResearchReports.com
Company Coverage: (Partial List)
1. Bial - Portela & Ca SA
2. Biogen Inc
3. Bristol-Myers Squibb Company
4. Camurus AB
5. Capricor Therapeutics Inc
6. Celsion Corp
7. Celtaxsys Inc
8. Chiesi Farmaceutici SpA
9. Chugai Pharmaceutical Co Ltd
10. Complexa Inc
11. Eli Lilly and Company
12. Galectin Therapeutics Inc
13. GlaxoSmithKline Plc
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

12. www.MarketResearchReports.com
Custom Research:
 Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
marketing research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center
For regular industry updates subscribe to our newsletter
at:
http://www.marketresearchreports.com/subscribe-to-
newsletter

13. www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://mrr.cm/UHD
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Mr. Sudeep Chakravarty
Email : info@marketresearchreports.com
Phone: +1-302-703-9904 (USA) +91-8762746600 (India)